Navigation Links
Adeona's Multiple Sclerosis Trial Receives $409,426 Grant
Date:3/28/2011

ooking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, a lack of funding despite the recent grants, our failure to successfully commercialize a new oral therapy for multiple sclerosis, the availability of additional financial and other resources and the allocation of resources among different potential uses, a failure of our clinical trial to complete enrollment in the anticipated time period or to achieve desired results, and other factors described in Adeona's report on Form 10-K for the year ended December 31, 2009 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Adeona undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.


'/>"/>
SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014  Hill-Rom Holdings, Inc. (NYSE: ... management presentation at the Morgan Stanley Global Healthcare Conference ... You are invited to listen to the live ... or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A ... hour after conclusion of the live event and accessible ...
(Date:8/27/2014)... An experimental drug designed to help regulate the blood,s iron ... of inflammation, according to results from the first human ... Blood , the Journal of the American ... a condition that occurs when red blood cells are in ... has anemia, the body does not get enough oxygen, since ...
(Date:8/27/2014)... YORK , Aug. 27, 2014 ... new market research report is available ... Chinese Guidebook for Application and Approval ... Regulations to Practices (2014 Edition) ... Now, Chinese regulations ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... , NEW YORK, Nov. 20 ... report is available in its catalogue. , ... , http://www.reportlinker.com/p0164373/Pipettes--Pipettors---A-Global-Market-Perspective.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , ... part of any research laboratory. Large-scale applications in ...
... , NATICK, Mass. and LONDON, ... BSX ) today announced that it has received 510(k) ... and CE Mark approval to market its WallFlex® Fully ... strictures (obstructions) caused by tumors in patients with resectable ...
Cached Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4
(Date:8/28/2014)... 28, 2014 Tea Leaves Health ... Gigya, the leader in Connected Consumer Management. By ... will have the opportunity to build more authentic ... they are and how they like to interact. ... world’s biggest brands to understand and connect with ...
(Date:8/28/2014)... MA (PRWEB) August 28, 2014 Now in ... run/walk that was started in 2011 by two brain aneurysm ... raise much needed awareness, provide education to help increase early ... been impacted by a brain aneurysm. We hope that you ... a worthy cause at the 4th Annual Step for Hope ...
(Date:8/28/2014)... Houston, Texas (PRWEB) August 28, 2014 ... Program. The program is a chance for regular customers ... MMAR Medical without the need for a wholesale license. ... athletics coaches, semi-professional athletic programs and others who regularly ... point. , “Whether supporting your own active lifestyle ...
(Date:8/28/2014)... The revenue cycle process touches on nearly everything ... patient books an appointment with a physician’s office, until ... services rendered to the healthcare provider. Medorizon ... RCM process down to a science. Over the past ... in nearly every healthcare facility around the globe. While ...
(Date:8/28/2014)... 2014 UniVoIP, Inc, a managed ... today announced that they have been certified with the ... Local Small Business Enterprise (Local SBE) Preference Programs. “We ... the state of California and LA county and excited ... Solution to governmental agencies throughout the state,“ says ...
Breaking Medicine News(10 mins):Health News:Tea Leaves Health Begins Important New Partnership with Gigya 2Health News:Tea Leaves Health Begins Important New Partnership with Gigya 3Health News:Step for Hope and Raise Brain Aneurysm Awareness 2Health News:MMAR Medical Announces Customer Membership Program 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 3Health News:Cloud PBX Provider UniVoIP Gets Certified by the State of California and the County of Los Angeles Under the Local Small Business Enterprise (SBE) Preference Program 2
... Oct. 26 Paramount Acquisition Corp.,(OTC Bulletin Board: PMQC, ... of 100% of the outstanding stock of B.J.K.,Inc., a ... Rx"),pursuant to a Stock Purchase Agreement, by and among ... June 1, 2007, as amended. Effective as,of the closing ...
... Genta,Incorporated (Nasdaq: GNTA ) announced today ... the Company,s Board of Directors. Dr.,McCaughey has served ... noted author and health policy expert, we appreciate ... infections from,multiply resistant organisms, along with her increasing ...
... Donations of more than $1 million worth of prescription medicines and ... ... GlaxoSmithKline,(NYSE: GSK ) shares the nation,s concern for residents and ... fires.,As a demonstration of support, GSK has offered to the people ...
... at Buffalo,s Research Institute on Addictions (RIA) is initiating ... used in behavioral medicine for stress reduction but not ... use disorders. , ... MBSR in alcoholism treatment, we hope to develop an ...
... proprietary ... technology-, MADISON, ... nation,s leading provider of diagnostic,testing, information and services, announced today that ... tracking technology,underlying Pathway Diagnostics, SensiTrop(TM) HIV co-receptor tropism test.,Tropism refers to ...
... PRAIRIE, Minn., Oct. 26 Most people learn about,long term care the ... that is when they find out that: -- Long term care ... health insurance, disability or HMO plan; and ... you have very limited income and assets. Even ...
Cached Medicine News:Health News:Paramount Completes Acquisition of Chem Rx 2Health News:Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors 2Health News:Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors 3Health News:GlaxoSmithKline Aids California Fire Relief Efforts 2Health News:Dealing with stress as a treatment for alcohol abuse 2Health News:Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics 2Health News:Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics 3Health News:Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics 4Health News:Congress Declares 'Long Term Care Awareness Week' - Long Term Care Group, Inc. Continues Related Work 2
Quick Release Holder designed for the 8000 Series Microtome to hold hardboard squares....
... rotary retracting, self-lubricating design and has a heavy ... construction makes it accurate and incredibly reliable. ,The ... lateral motion is controlled and allows no slop ... lesser designs which can result in 'chatter' and ...
Allows for custom orientation of specimen...
Disposable Feather Blades, 50 per pack...
Medicine Products: